245 related articles for article (PubMed ID: 14715831)
1. Features of the metabolic syndrome after childhood craniopharyngioma.
Srinivasan S; Ogle GD; Garnett SP; Briody JN; Lee JW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):81-6. PubMed ID: 14715831
[TBL] [Abstract][Full Text] [Related]
2. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Kendall-Taylor P; Jönsson PJ; Abs R; Erfurth EM; Koltowska-Häggström M; Price DA; Verhelst J
Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity.
Cruz ML; Weigensberg MJ; Huang TT; Ball G; Shaibi GQ; Goran MI
J Clin Endocrinol Metab; 2004 Jan; 89(1):108-13. PubMed ID: 14715836
[TBL] [Abstract][Full Text] [Related]
4. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
7. Syndrome X in 8-y-old Australian children: stronger associations with current body fatness than with infant size or growth.
Dwyer T; Blizzard L; Venn A; Stankovich JM; Ponsonby AL; Morley R
Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1301-9. PubMed ID: 12355325
[TBL] [Abstract][Full Text] [Related]
8. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin independently predicts metabolic syndrome in overweight Latino youth.
Shaibi GQ; Cruz ML; Weigensberg MJ; Toledo-Corral CM; Lane CJ; Kelly LA; Davis JN; Koebnick C; Ventura EE; Roberts CK; Goran MI
J Clin Endocrinol Metab; 2007 May; 92(5):1809-13. PubMed ID: 17311859
[TBL] [Abstract][Full Text] [Related]
11. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery.
Sahakitrungruang T; Klomchan T; Supornsilchai V; Wacharasindhu S
Eur J Pediatr; 2011 Jun; 170(6):763-9. PubMed ID: 21107605
[TBL] [Abstract][Full Text] [Related]
12. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma.
Simoneau-Roy J; O'Gorman C; Pencharz P; Adeli K; Daneman D; Hamilton J
Clin Endocrinol (Oxf); 2010 Mar; 72(3):364-70. PubMed ID: 19486023
[TBL] [Abstract][Full Text] [Related]
14. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
Johannsson G; Albertsson-Wikland K; Bengtsson BA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity indices of glucose and free fatty acid metabolism in obese children and adolescents in relation to serum lipids.
Reinehr T; Kiess W; Andler W
Metabolism; 2005 Mar; 54(3):397-402. PubMed ID: 15736120
[TBL] [Abstract][Full Text] [Related]
18. Hormonal factors influencing weight and growth pattern in craniopharyngioma.
Pinto G; Bussières L; Recasens C; Souberbielle JC; Zerah M; Brauner R
Horm Res; 2000; 53(4):163-9. PubMed ID: 11044799
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.
De Marinis L; Bianchi A; Mancini A; Gentilella R; Perrelli M; Giampietro A; Porcelli T; Tilaro L; Fusco A; Valle D; Tacchino RM
J Clin Endocrinol Metab; 2004 Jan; 89(1):174-80. PubMed ID: 14715846
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.
van Dijk M; Bannink EM; van Pareren YK; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Jan; 92(1):160-5. PubMed ID: 17062774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
